Medicare Price Cuts Drive Labs to Sell or File BK

CEO SUMMARY: Professional investors are smart with their money. Thus, it is no surprise that clinical lab and pathology companies owned by private equity firms are the first to be sold or closed. These investors are acting in response to the cumulative negative financial impact of recent cuts to lab test prices. Even more worrisome …

Medicare Price Cuts Drive Labs to Sell or File BK Read More »

To access this post, you must purchase The Dark Report.

Medicare Price Cuts Drive Labs to Sell or File BK

It is the first wave of lab restructuring and is market evidence of deteriorating lab finances

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month